Search

Patients with a rare blood cancer that had relapsed or become resistant to treatment have shown a high response rate to a potent new immunotherapy drug, in a Peter Mac-led clinical trial. The early-phase NP30179 trial involved... Read more

ProsTIC Leadership Team Professor Michael Hofman - Director of Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC); Nuclear Medicine and Molecular Imaging Physician  Professor Declan Murphy - Director... Read more

As part of Breast Cancer Awareness Month, the ABC’s Jacinta Parsons will engage in conversation with authors and breast cancer survivors Patrice Capogreco and Danna Diaz who will share their stories and the ripple effect... Read more

Our key publications  Latest Published Research Latest Published ResearchThe UpFrontPSMA Trial: Lu-PSMA in men with newly diagnosed prostate... Read more

  It will take approximately 30 minutes to complete iPrevent. You will be able to download a personalised report that you can discuss with your doctor.  iPrevent should not be used if you have had invasive breast... Read more

2026 Preceptorship: More details to be announced.  The ProsTIC Preceptorship biennial event is returning in 2026 with further details to be confirmed. Please follow our social media to stay up-to-date on upcoming... Read more